Passive immunity for the treatment of influenza: quality not quantity
Open Access
- 30 September 2019
- journal article
- editorial
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 7 (11) , 922-923
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trialThe Lancet Respiratory Medicine, 2019
- Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trialThe Lancet Respiratory Medicine, 2019
- Antibody-dependent enhancement of severe dengue disease in humansScience, 2017
- Comprehensive serological profiling of human populations using a synthetic human viromeScience, 2015
- Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced ProtectionThe Journal of Infectious Diseases, 2011
- Antibody Repertoire: Embracing DiversityScience Translational Medicine, 2011
- Antiviral antibody responses: the two extremes of a wide spectrumNature Reviews Immunology, 2006
- A CLINICAL, EPIDEMIOLOGICAL AND IMMUNOLOGICAL EVALUATION OP VACCINATION AGAINST EPIDEMIC INFLUENZA12American Journal of Epidemiology, 1945
- TREATMENT OF INFLUENZA PNEUMONIA BY THE USE OF CONVALESCENT HUMAN SERUMJAMA, 1918